ストックスクリーナーアプリを入手
21.42
0.09%
0.02
アフターアワーズ：
21.45
0.03
+0.14%
前日終値:
$21.40
開ける：
$21.42
24時間の取引高:
1.39M
Relative Volume:
0.49
時価総額：
$2.10B
収益：
$221.08M
当期純損益:
$-2.92M
株価収益率:
-649.09
EPS:
-0.033
ネットキャッシュフロー:
$5.89M
1週間 パフォーマンス:
+0.14%
1か月 パフォーマンス:
-6.63%
6か月 パフォーマンス:
+129.83%
1年 パフォーマンス:
+107.36%
1日の値動き範囲:
$21.38
$21.45
1週間の範囲:
$21.34
$21.45
52週間の値動き範囲:
$6.38
$23.57
Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile
名前
Avadel Pharmaceuticals Plc
セクター
電話
636-449-1830
住所
10 EARLSFORT TERRACE, DUBLIN 2
AVDL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AVDL
Avadel Pharmaceuticals Plc
|
21.42 | 2.10B | 221.08M | -2.92M | 5.89M | -0.033 |
|
ZTS
Zoetis Inc
|
122.76 | 53.87B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.83 | 45.71B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.84 | 43.73B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.32 | 34.49B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
507.00 | 22.00B | 3.08B | 1.24B | 1.07B | 25.61 |
Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-23 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2025-09-03 | 開始されました | Wells Fargo | Equal Weight |
| 2025-07-18 | 再開されました | H.C. Wainwright | Buy |
| 2025-02-11 | 開始されました | Deutsche Bank | Buy |
| 2024-06-12 | 開始されました | Rodman & Renshaw | Buy |
| 2024-03-05 | 繰り返されました | H.C. Wainwright | Buy |
| 2024-03-05 | 繰り返されました | Needham | Buy |
| 2024-03-05 | 繰り返されました | Oppenheimer | Outperform |
| 2024-02-06 | 開始されました | UBS | Buy |
| 2022-11-30 | アップグレード | Jefferies | Hold → Buy |
| 2022-08-10 | ダウングレード | Jefferies | Buy → Hold |
| 2022-07-28 | 再開されました | Craig Hallum | Buy |
| 2022-05-26 | ダウングレード | Stifel | Buy → Hold |
| 2021-09-23 | 開始されました | Needham | Buy |
| 2020-07-31 | 開始されました | Oppenheimer | Outperform |
| 2020-07-21 | 開始されました | SVB Leerink | Outperform |
| 2020-06-30 | 開始されました | H.C. Wainwright | Buy |
| 2020-04-03 | 開始されました | Jefferies | Buy |
| 2020-03-12 | 開始されました | Stifel | Buy |
| 2020-02-26 | 開始されました | Piper Sandler | Overweight |
| 2020-01-30 | 開始されました | Craig Hallum | Buy |
| 2019-06-14 | アップグレード | Ladenburg Thalmann | Neutral → Buy |
| 2019-02-08 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
すべてを表示
Avadel Pharmaceuticals Plc (AVDL) 最新ニュース
Bank of America discloses 2.1% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Citadel Group discloses 1.21% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Canada
BlackRock discloses 6.98% stake in Avadel Pharmaceuticals - Investing.com
TIG Advisors discloses 4.01% stake in Avadel Pharmaceuticals - Investing.com India
Bank of America discloses 2.1% stake in Avadel Pharmaceuticals - Investing.com India
Goldman Sachs discloses trading position in Avadel Pharmaceuticals By Investing.com - Investing.com UK
Avadel Completes Enrollment in Phase 3 LUMRYZ Trial - TipRanks
Avadel completes enrollment in phase 3 trial for sleep disorder drug - Investing.com
Avadel Pharmaceuticals Completes Patient Enrollment for REVITALYZ Phase 3 Trial of LUMRYZ™ in Idiopathic Hypersomnia - Quiver Quantitative
Avadel Pharmaceuticals Completes Enrollment in Phase 3 REVITALYZ Trial - TradingView — Track All Markets
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares - Investing.com
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares By Investing.com - Investing.com Canada
Morgan Stanley discloses client-serving trades in Avadel Pharmaceuticals By Investing.com - Investing.com Canada
JPMorgan discloses dealings in Avadel Pharmaceuticals amid takeover By Investing.com - Investing.com Nigeria
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Morgan Stanley discloses dealings in Avadel Pharmaceuticals securities By Investing.com - Investing.com Nigeria
BlackRock discloses 7.08% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Citadel Group discloses 1.2% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
FIL Limited discloses 2.9% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
FIL Limited discloses 2.9% stake in Avadel Pharmaceuticals - Investing.com India
BlackRock discloses 7.08% stake in Avadel Pharmaceuticals - Investing.com
Form 8.3Avadel Pharmaceuticals plc - The Manila Times
Bank of America discloses 2.07% stake in Avadel Pharmaceuticals - Investing.com
Bank of America discloses 2.07% stake in Avadel Pharmaceuticals By Investing.com - Investing.com UK
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals - Investing.com
Morgan Stanley discloses dealings in Avadel Pharmaceuticals shares By Investing.com - Investing.com Australia
Morgan Stanley discloses dealings in Avadel Pharmaceuticals shares - Investing.com
Janus Henderson discloses 3.58% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Citadel Group discloses 1.21% stake in Avadel Pharmaceuticals - Investing.com
BlackRock discloses 7.06% stake in Avadel Pharmaceuticals By Investing.com - Investing.com UK
Goldman Sachs discloses trading position in Avadel Pharmaceuticals - Investing.com India
Janus Henderson discloses 3.58% stake in Avadel Pharmaceuticals - Investing.com
Bank of America discloses 2% stake in Avadel Pharmaceuticals - Investing.com India
Bank of America discloses 1.9% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Bank of America discloses 1.9% stake in Avadel Pharmaceuticals - Investing.com
Halper Sadeh LLC Encourages AVDL, CMA, KVUE Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire Inc.
Market Moves: How higher bond yields impact Avadel Pharmaceuticals plc AWK stockPrice Action & Daily Chart Pattern Signal Reports - moha.gov.vn
Avadel Pharmaceuticals PLC. $AVDL Position Lowered by Gendell Jeffrey L - MarketBeat
AWM Investment Company Inc. Purchases 275,189 Shares of Avadel Pharmaceuticals PLC. $AVDL - MarketBeat
Avadel Pharmaceuticals Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avadel Pharmaceuticals plcAVDL - PR Newswire
Goldman Sachs (EPT)38.5bAVADEL PHARMACEUTICALS PLC - Research Tree
Geode Capital discloses 2.24% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Canada
Geode Capital discloses 2.24% stake in Avadel Pharmaceuticals - Investing.com
Bank of America discloses 1.88% stake in Avadel Pharmaceuticals By Investing.com - Investing.com South Africa
Bank of America discloses 1.88% stake in Avadel Pharmaceuticals - Investing.com
Avadel Pharmaceuticals Plc (AVDL) 財務データ
収益
当期純利益
現金流量
EPS
12.55%
0.77%
大文字化:
|
ボリューム (24 時間):